ANI Pharmaceuticals
ANIP
ANIP
117 hedge funds and large institutions have $214M invested in ANI Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.31% more ownership
Funds ownership: 59.37% → 59.68% (+0.31%)
7% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 42
Holders
117
Holding in Top 10
–
Calls
$1.11M
Puts
$784K
Top Buyers
| 1 | +$4.67M | |
| 2 | +$2.16M | |
| 3 | +$1.34M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$1.09M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.08M |
Top Sellers
| 1 | -$7.3M | |
| 2 | -$1.43M | |
| 3 | -$1.1M | |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$673K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
-$561K |